SCHEMBL10047244

SCHEMBL10047244

CCCC[C@@H]1[C@@H](Sc2ccc(OC)cc2)[C@@H](C(=O)O)[C@H](c2cccc(F)c2)N1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RABGGTB P53611 7/20 0.68
RABGGTA Q92696 7/20 0.68
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
P2RX3 P56373 1/20 0.35
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPT P10636 1/20 0.35
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073587 1.00 RABGGTB (0.68) RABGGTBRABGGTACRHBPCRHR2CYP1A2
SCHEMBL14882763 0.95 RABGGTB (0.75) RABGGTBRABGGTACRHBPCRHR2CYP1A2
SCHEMBL14885242 0.95 RABGGTB (0.75) RABGGTBRABGGTACRHBPCRHR2CYP1A2
SCHEMBL14882697 0.94 RABGGTB (0.59) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL10047275 0.94 RABGGTB (0.59) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL10073605 0.94 RABGGTB (0.59) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL14882764 0.90 RABGGTB (0.65) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL10047279 0.90 RABGGTB (0.65) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL10072992 0.90 RABGGTB (0.65) RABGGTBRABGGTACRHBPCRHR2USP2
SCHEMBL14882622 0.86 RABGGTB (0.66) RABGGTBRABGGTACRHBPCRHR2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB RABGGTB 17/4885RABGGTA 5/4885CRHBP 3692/4885
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB RABGGTB 3/4885RABGGTA 1/4885CRHBP 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.